Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Biogen Idec Ma Inc
Biogen Idec Ma Inc A Corporation
Biogen Idec Ma Inc And Mclean Hospital
Biogen Idec Ma Inc_20100114
Biogen Idec Ma Inc_20100121
  

Biogen Idec Ma Inc patents

Recent patent applications related to Biogen Idec Ma Inc. Biogen Idec Ma Inc is listed as an Agent/Assignee. Note: Biogen Idec Ma Inc may have other listings under different names/spellings. We're not affiliated with Biogen Idec Ma Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Biogen Idec Ma Inc-related inventors




Date Biogen Idec Ma Inc patents (updated weekly) - BOOKMARK this page
10/26/17Administration of agents for the treatment of inflammation
12/08/16Recombinant factor viii proteins
10/13/16Methods of using a fixed dose of a clotting factor
07/14/16Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
05/05/16Fc receptor (fcrn) binding peptides and uses thereof
12/10/15Chimeric clotting factors
12/03/15Anti-neublastin antibodies and uses thereof
11/19/15Use of dr6 antagonists to improve motor neuron disease
10/29/15Methods and compositions for inactivating enveloped viruses
10/22/15S1p and/or atx modulating agents
10/15/15Methods for treating tweak-related conditions
10/01/15S1p and/or atx modulating agents
09/24/15Methods of using fviii polypeptide
09/10/15Methods of using fix polypeptides
09/03/15Atx modulating agents
09/03/15Polyalkylene polymer compounds and uses thereof
08/27/15Combination therapies and uses for treatment of demyelinating disorders
08/20/15Heterobicyclic sphingosine 1-phosphate analogs
08/06/15Taci as an anti-tumor agent
08/06/15Methods for the detection of jc polyoma virus
08/06/15Disease progression parameters and uses thereof for evaluating multiple sclerosis
07/30/15Atx modulating agents
07/30/15Enhancement of transport of therapeutic molecules across the blood brain barrier
07/30/15Isolation and use of human regulatory t cells
07/23/15Compounds that are s1p modulating agents and/or atx modulating agents
07/23/15Compounds that are s1p modulating agents and/or atx modulating agents
07/23/15Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
07/09/15Cell line expressing single chain factor viii polypeptides and uses thereof
07/02/15Compounds that are s1p modulating agents and/or atx modulating agents
07/02/15Procoagulant compounds
07/02/15Blood factor monitoring assay and uses thereof
06/25/15Extended treatment of multiple sclerosis
06/25/15Nogo receptor binding protein
06/18/15Device container
06/18/15Trapping reagents for reactive metabolites screening
06/11/15Pyrimidinyl tyrosine kinase inhibitors
06/11/15Factor viii compositions and methods of making and using same
06/04/15Administration of agents for the treatment of inflammation
05/21/15Baff receptor (bcma), an immunoregulatory agent
05/21/15Anti-alpha(v)beta(6) antibodies
05/14/15Polyalkylene polymer compounds and uses thereof
05/14/15Treatment of neurodegeneration and neuroinflammation
05/07/15Anti-bcma antibodies
05/07/15Inhibitors of bruton's tyrosine kinase
04/30/15Lingo-2 antagonists for treatment of conditions involving motor neurons
04/23/15Cognitive composite parameters and uses thereof for evaluating multiple sclerosis
04/23/15Anti-tim-1 antibodies and uses thereof
04/09/15Methods of treating a patient having an autoimmune disorder by administering a baff antagonist
04/02/15Stable liquid interferon formulations
03/26/15Biomarkers for use in integrin therapy applications
03/19/15Method for delivering interferon-beta
03/19/15Methods of detecting glycosaminoglycans
03/12/15Methods and products for evaluating an immune response to a therapeutic protein
03/05/15Therapeutic uses of humanized antibodies against alpha-4 integrin
02/26/15Jcv neutralizing antibodies
02/26/15Steroid sparing agents and methods of using same
02/26/15Delivery device and components thereof
02/19/15Jcv neutralizing antibodies
02/12/15Immunoglobulin formulation and preparation thereof
02/05/15High-throughput sialic acid quantitation
01/29/15Treatment of severe multiple sclerosis
01/29/15Biomarkers for multiple sclerosis and methods of use thereof
01/22/15Chimeric factor viii polypeptides and uses thereof
01/22/15Methods of modulating immunological responses by administering truncated baff receptors
01/15/15Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
Patent Packs
12/18/14Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
12/11/14Cholesterol-based media supplements for cell culture
12/04/14Use of nuclear magnetic resonance and near infrared to analyze biological samples
11/27/14Treatment using neublastin polypeptides
11/20/14Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
10/30/14Method of assessing risk of pml
10/30/14Refolding transforming growth factor beta family proteins
10/30/14Neuroprotection in demyelinating diseases
10/16/14Factor viii polypeptide formulations
10/16/14Bicyclic aryl sphingosine 1-phosphate analogs
10/09/14Pro-coagulant compounds and methods of use thereof
10/02/14Anti-alpha(v)beta(6) antibodies and uses thereof
10/02/14Methods of preventing and removing trisulfide bonds
09/18/14Methods of evaluating baff
09/11/14Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use
Patent Packs
09/11/14Assay for detection of jc virus dna
08/21/14Therapies for chronic renal failure using one or more integrin antagonists
08/14/14Nogo receptor antagonists
08/07/14Anti-cd154 antibodies
08/07/14Drug labeling tool
07/31/14Methods for use with baff antagonists
07/17/14Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
07/17/14Sp35 antibodies and uses thereof
07/17/14Process for preparing high purity and crystalline dimethyl fumarate
07/10/14Deuterium substituted fumarate derivatives
07/03/14Spectroscopic analysis of nutrient materials for use in a cell culture process
07/03/14Novel receptor nucleic acids and polypeptides
06/26/14Antibodies against monocyte chemotactic proteins
06/12/14Anti-vla-4 antibodies
06/12/14Methods of treating multiple sclerosis and preserving and/or increasing myelin content
06/05/14Method for the treatment of inflammatory disorders
05/08/14Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
03/20/14Humanized antibodies against monocyte chemotactic proteins
03/20/14Linker peptides and polypeptides comprising same
03/20/14Anti-lymphotoxin antibodies
03/06/14Automated monitoring chromatography column performance, and applications thereof
01/16/14Cripto binding molecules
01/09/14Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
12/26/13Heterocyclic tyrosine kinase inhibitors
12/19/13Sp35 antibodies and uses thereof
12/19/13Methods for determining differences in alpha-4 integrin activity by correlating differences in svcam and/or smadcam levels
12/05/13Composition comprising antibodies to lingo or fragments thereof
11/28/13Nrf2 screening assays and related methods and compositions
10/03/13Treatment of autoimmune disorders
09/12/13Compositions and methods for increasing vascularization
Social Network Patent Pack
09/05/13Method of treating a patient having an autoimmune disorder by administering baffr polypeptide
08/22/13Methods for treating tweak-related conditions
08/22/13Ltbr blockade: methods for optimizing therapeutic responsiveness of patients
08/01/13Methods of evaluating baff
08/01/13Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
07/25/13Platelet aggregation assays
07/18/13Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
07/11/13Method of treating immunological disorders by administering truncated baff receptors
05/23/13Treatment using neublastin polypeptides
05/02/13Novel neurotrophic factors
Patent Packs
04/25/13Light targeting molecules and uses thereof
04/25/13Methods for the detection of jc polyoma virus
04/18/13Treating neurological disorders
04/18/13Neublastin variants
04/18/13Method of supplementing culture media to prevent undesirable amino acid substitutions
04/11/13Kim-1 antibodies for treatment of th2-mediated conditions
03/14/13Nutrient monitoring and feedback control for increased bioproduct production
01/17/13Antibody formulations
01/10/13Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
01/03/13Detection and quantitation of cyclodextrins
12/20/12Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/13/12Polymer-conjugated glycosylated neublastin
11/08/12Biomarkers and assays for the treatment of cancer
10/18/12Anti-vla-4 related assays
10/18/12Methods of preventing and removing trisulfide bonds
10/11/12Methods for the detection of jc polyoma virus
10/11/12Treatment for amyotrophic lateral sclerosis
10/04/12Anti-alpha v beta 6 antibodies
09/27/12Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
09/13/12Nogo receptor binding protein
09/13/12Methods of evaluating baff
08/23/12Methods of targeting baff
08/02/12Cripto blocking antibodies and uses thereof
08/02/12Treatment for multiple sclerosis
07/26/12Taci as an anti-tumor agent
07/26/12Sp35 antibodies and uses thereof
07/26/12Bicyclic aryl sphingosine 1-phosphate analogs
07/19/12Treating neurological disorders
07/12/12Antibodies to vla-1
06/28/12Treatment of neurodegeneration and neuroinflammation
Patent Packs
06/21/12Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/12Heteroaryl btk inhibitors
06/21/12Bruton's tyrosine kinase inhibitors
05/31/12Antibody formulations
04/26/12Stabilized fc polypeptides with reduced effector function and methods of use
04/26/12Antibodies having altered effector function and methods for making the same
04/12/12Method for the treatment of inflammatory disorders
04/05/12Treatment using neublastin polypeptides
03/22/12Method of identifying compounds that bind baff-r
03/15/12Human ly6-big molecules and methods of use
03/08/12Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta
03/01/12Purification of immunoglobulins
02/16/12Antibodies against monocyte chemotactic proteins
02/02/12Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
01/26/12Methods for pancreatic tissue regeneration
01/26/12Methods of evaluating patients
01/26/12Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins
01/26/12Recombinant anti-vla4 antibody molecules
01/19/12Treating and evaluating inflammatory disorders
01/19/12Composition comprising antibodies to lingo or fragments thereof
Social Network Patent Pack
01/19/12Methods for treating tweak-related conditions
01/19/12Arginine inactivation of viruses
01/12/12Tweak binding antibodies
01/05/12Neonatal fc receptor (fcrn)- binding polypeptide variants, dimeric fc binding proteins and methods related thereto
01/05/12Anti-lymphotoxin antibodies
12/22/11Truncated baff receptors
12/22/11Sp35 antibodies and uses thereof
12/15/11Anti-alpha v beta 6 antibodies and uses thereof
12/08/11Stabilized polypeptide compositions
12/01/11Compositions and methods for inhibiting growth of smad-4 deficient cancers
11/17/11Modulators of mitotic kinases
10/13/11Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/06/11Single chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
10/06/11Cancer stem cells
09/29/11Humanized antibodies against monocyte chemotactic proteins
08/04/11Antibodies to vla-1
06/23/11Automated monitoring chromatography column performance, and applications thereof
06/23/11Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
06/09/11Anti-neublastin antibodies and uses thereof
06/02/11Purified immunoglobulin fusion proteins and methods of their purification
Social Network Patent Pack
05/26/11Use of nogo receptor-1 (ngr1) for promoting oligodendrocyte survival
05/26/11Use of lingo-4 antagonists in the treatment of conditions involving demyelination
05/12/11Therapeutic regimens for baff antagonists
03/10/11Gapr-1 methods
03/03/11Taj in neuronal function
02/24/11Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
01/27/11Modified antibodies and methods of use
01/27/11Modulators of interleukin-1 receptor-associated kinase
01/06/11Tweak receptor agonists as anti-angiogenic agents
12/30/10Cripto binding molecules
12/09/10Methods of manufacturing a biologic using a stable storage intermediate
12/09/10Novel receptor nucleic acids and polypeptides
11/25/10Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of lingo-1 antagonists and trkb agonists
11/11/10Biomarkers of multiple sclerosis
10/28/10Antibodies to vla-1
10/28/10Treatment of cancer
10/21/10Systemic administration of colony stimulating factors to treat amyloid associated disorders
10/21/10Receptor coupling agents and therapeutic uses thereof
10/21/10Compositions and methods to treat acute myelogenous leukemia
10/14/10Compositions and methods for increasing vascularization
09/30/10Modulators of mitotic kinases
09/23/10Bicyclic sphingosine 1-phosphate analogs
08/12/10Cripto blocking antibodies and uses thereof
08/12/10Recombinant anti-vla4 antibody molecules
08/12/10Fc gamma receptor-binding polypeptide variants and methods related thereto
08/12/10Nogo receptor binding protein
07/22/10Truncated baff receptors
07/01/10Altered br-3 binding polypeptides
07/01/10Antibodies against monocyte chemotactic proteins
07/01/10Method of treating a pathological syndrome
Social Network Patent Pack
06/24/10Expression cassette and vector for transient or stable expression of exogenous molecules
06/24/10Bicyclic aryl sphingosine 1-phosphate analogs
06/17/10Kim-1 antibodies for treatment of th2-mediated conditions
06/03/10Treatment of follicular lymphomas using inhibitors of the lt pathway
06/03/10Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
05/27/10Systems and methods for evaluating chromatography column performance
05/13/10Light targeting molecules and uses thereof
04/29/10Furanone compounds and methods of making and using the same
04/29/10Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
04/22/10Anti-igf-1r antibodies and uses thereof
04/22/10Anti-igf-1r antibodies and uses thereof
04/15/10Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
04/01/10Kim-1 antagonists and use to modulate immune system
03/25/10Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of sp35 or trka antagonists
03/18/10Nutrient monitoring and feedback control for increased bioproduct production
03/11/10Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
03/11/10Biomarkers for multiple sclerosis and methods of use thereof
03/04/10Compositions and methods for administering gdnf ligand family proteins
03/04/10Substituted pyrazalones
02/18/10Composition and methods for the detection of cripto-3
02/11/10Imidazolone compounds and methods of making and using the same
01/21/10Composition comprising antibodies to lingo or fragments thereof
01/14/10Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
12/31/09Method for the treatment of inflammatory disorders
12/31/09Anti-fn14 antibodies and uses thereof
12/17/09Methods for treating tweak-related conditions
12/17/09System and bioprocess control
12/10/09Methods of treating fibrosis
11/26/09Therapeutic combinations of anti-igf-1r antibodies and other compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Biogen Idec Ma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Biogen Idec Ma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';